Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

SmithKline Beecham's Famvir receives U.K. approval for new indication

May 21, 1997

Fujisawa describes new cephems

May 21, 1997

Xoma issued U.S. patent for antifungal uses of BPI-derived products

May 20, 1997

Aronex extends clinical trials with Nyotran

May 20, 1997

Abelcet earns regulatory approval in Switzerland

May 16, 1997

SmithKline Beecham and LG Chemical sign agreement for new antibiotic

May 14, 1997

Promising results reported on new complex carbohydrate antifungal compound

May 14, 1997

Bristol-Myers Squibb launches Vagistat-1 as OTC in the U.S.

May 13, 1997

Penederm receives approval for butenafine in Canada

May 12, 1997

Wakunaga prepares novel antibacterial agents

May 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.